Nuvation Bio

We successfully finished our first global fitness challenge last month! Together we covered nearly 10,298 miles for The Leukemia & Lymphoma Society via Charity Miles. We are proud of the teamwork and dedication our colleagues showed to support this important organization, while sneaking in some exercise, too! #biotech #oncology #cancer

Chris Richards, CPC, Nuvation Bio’s Senior Director, Commercial Learning & Development, combines her certified professional coaching skills and passion for making a difference for patients with #cancer. With an exciting year ahead expected for our team as we plan for potential FDA approval for our lead #ROS1 inhibitor for #NSCLC, we welcome Chris’ leadership in designing and executing a best-in-class new hire onboarding program for our Commercial team. Explore our open positions: https://bit.ly/4fadgvH

Don’t miss Nuvation Bio’s fireside chat tomorrow at the 7th Annual Evercore ISI HealthCONx Conference. David Hung, M.D., our Founder, President, and CEO, will discuss the latest updates from our lead #ROS1 inhibitor program, which position us to potentially become a commercial-stage company next year, and the momentum across the rest of our #oncology pipeline. Watch here: https://bit.ly/3Vazma1

As we gather with loved ones this Thanksgiving, we want to take a moment to express our gratitude to our team, patients, investigators, and everyone else who makes it possible for us to develop treatments for the most difficult-to-treat #cancers. Thank you!

During #LungCancerAwarenessMonth, we are raising awareness about #ROS1 positive #NSCLC. Despite advances, new treatment options are urgently needed. At Nuvation Bio, we are passionate about changing the reality for patients and making a positive difference for them. #LCAM #lungcancer #oncology

Jean-Yves Maziere, MD, MS, Vice President of Pharmacovigilance, recently joined Nuvation. With oncology as the “center of gravity” for Jean-Yves in a long career focused on clinical, pharmacovigilance, and data science, he is excited to lead a global team of talented professionals during a critical part of our history as we evolve towards a commercial stage company. Learn more about our team’s impact: https://bit.ly/3YZuV44 #NUVBeginnings #oncology #cancer

Don’t miss Nuvation Bio’s presentation at the Jefferies London Healthcare Conference next Tuesday, where David Hung, M.D., our Founder, President, and CEO, will highlight plans for our lead #ROS1 inhibitor for #NSCLC, and progress across the rest of our #oncology pipeline. Learn more here: https://lnkd.in/eEwADBvE

Today we reported third quarter 2024 financial results and provided a business update. See more: https://bit.ly/48LyUEP #oncology #cancer #biotech 

As we launch wellness month here at Nuvation Bio, we believe it’s important to support our colleagues’ wellbeing, which is why we are excited for our 2nd Annual NUV on the Move initiative! This year we are proud to partner with The Leukemia & Lymphoma Society via Charity Miles to support a mission that’s close to our hearts. Learn about more ways our team is making an impact: https://shorturl.at/hkOFl

Please join us in welcoming Philippe Sauvage as our new Chief Financial Officer! Philippe brings over 20 years of global finance, operations, and commercialization experience across leading #healthcare and #biopharma companies that have made a difference for patients. He will be integral as we advance our mission to tackle some of the greatest unmet needs in #oncology. Read the announcement: https://lnkd.in/e3Q8f7pc